Tuesday, January 11, 2011

HORMONES

From Wikipedia, the free encyclopedia
  
Epinephrine (adrenaline), a catecholamine-type hormone
 
A hormone (from Greek ὁρμή - "impetus") is a chemical released by a cell or a gland in one part of the body that sends out messages that affect cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. In essence, it is a chemical messenger that transports a signal from one cell to another. All multicellular organisms produce hormones; plant hormones are also called phytohormones. Hormones in animals are often transported in the blood. Cells respond to a hormone when they express a specific receptor for that hormone. The hormone binds to the receptor protein, resulting in the activation of a signal transduction mechanism that ultimately leads to cell type-specific responses.
Endocrine hormone molecules are secreted (released) directly into the bloodstream, whereas exocrine hormones (or ectohormones) are secreted directly into a duct, and, from the duct, they flow either into the bloodstream or from cell to cell by diffusion in a process known as paracrine signalling.
Recently it has been found that a variety of exogenous modern chemical compounds have hormone-like effects on both humans and wildlife. Their interference with the synthesis, secretion, transport, binding, action, or elimination of natural hormones in the body are responsible of homeostasis, reproduction, development, and/or behavioural changes sameway as the endogenous produced hormones."[1]

Hormones as a signal

Hormonal signaling involves the following:[citation needed]
  1. Biosynthesis of a particular hormone in a particular tissue
  2. Storage and secretion of the hormone
  3. Transport of the hormone to the target cell(s)
  4. Recognition of the hormone by an associated cell membrane or intracellular receptor protein
  5. Relay and amplification of the received hormonal signal via a signal transduction process: This then leads to a cellular response. The reaction of the target cells may then be recognized by the original hormone-producing cells, leading to a down-regulation in hormone production. This is an example of a homeostatic negative feedback loop.
  6. Degradation of the hormone.
Hormone cells are typically of a specialized cell type, residing within a particular endocrine gland, such as thyroid gland, ovaries, and testes. Hormones exit their cell of origin via exocytosis or another means of membrane transport. The hierarchical model is an oversimplification of the hormonal signaling process. Cellular recipients of a particular hormonal signal may be one of several cell types that reside within a number of different tissues, as is the case for insulin, which triggers a diverse range of systemic physiological affects. Different tissue types may also respond differently to the same hormonal signal. Because of this, hormonal signaling is elaborate and hard to dissect.[citation needed]

Interactions with receptors

Most hormones initiate a cellular response by initially combining with either a specific intracellular or cell membrane associated receptor protein. A cell may have several different receptors that recognize the same hormone and activate different signal transduction pathways, or a cell may have several different receptors that recognize different hormones and activate the same biochemical pathway.
For many hormones, including most protein hormones, the receptor is membrane-associated and embedded in the plasma membrane at the surface of the cell. The interaction of hormone and receptor typically triggers a cascade of secondary effects within the cytoplasm of the cell, often involving phosphorylation or dephosphorylation of various other cytoplasmic proteins, changes in ion channel permeability, or increased concentrations of intracellular molecules that may act as secondary messengers (e.g., cyclic AMP). Some protein hormones also interact with intracellular receptors located in the cytoplasm or nucleus by an intracrine mechanism.
For hormones such as steroid or thyroid hormones, their receptors are located intracellularly within the cytoplasm of their target cell. To bind their receptors, these hormones must cross the cell membrane. They can do so because they are lipid-soluble. The combined hormone-receptor complex then moves across the nuclear membrane into the nucleus of the cell, where it binds to specific DNA sequences, effectively amplifying or suppressing the action of certain genes, and affecting protein synthesis.[2] However, it has been shown that not all steroid receptors are located intracellularly. some are associated with the plasma membrane.[3]
An important consideration, dictating the level at which cellular signal transduction pathways are activated in response to a hormonal signal, is the effective concentration of hormone-receptor complexes that are formed. Hormone-receptor complex concentrations are effectively determined by three factors:
  1. The number of hormone molecules available for complex formation
  2. The number of receptor molecules available for complex formation
  3. The binding affinity between hormone and receptor.
The number of hormone molecules available for complex formation is usually the key factor in determining the level at which signal transduction pathways are activated, the number of hormone molecules available being determined by the concentration of circulating hormone, which is in turn influenced by the level and rate at which they are secreted by biosynthetic cells. The number of receptors at the cell surface of the receiving cell can also be varied, as can the affinity between the hormone and its receptor.

Physiology of hormones

Most cells are capable of producing one or more molecules, which act as signaling molecules to other cells, altering their growth, function, or metabolism. The classical hormones produced by cells in the endocrine glands mentioned so far in this article are cellular products, specialized to serve as regulators at the overall organism level. However, they may also exert their effects solely within the tissue in which they are produced and originally released.
The rate of hormone biosynthesis and secretion is often regulated by a homeostatic negative feedback control mechanism. Such a mechanism depends on factors that influence the metabolism and excretion of hormones. Thus, higher hormone concentration alone cannot trigger the negative feedback mechanism. Negative feedback must be triggered by overproduction of an "effect" of the hormone.
Hormone secretion can be stimulated and inhibited by:
  • Other hormones (stimulating- or releasing -hormones)
  • Plasma concentrations of ions or nutrients, as well as binding globulins
  • Neurons and mental activity
  • Environmental changes, e.g., of light or temperature
One special group of hormones is the tropic hormones that stimulate the hormone production of other endocrine glands. For example, thyroid-stimulating hormone (TSH) causes growth and increased activity of another endocrine gland, the thyroid, which increases output of thyroid hormones.
A recently identified class of hormones is that of the "hunger hormones" - ghrelin, orexin, and PYY 3-36 - and "satiety hormones" - e.g., cholecystokinin, leptin, nesfatin-1, obestatin.
To release active hormones quickly into the circulation, hormone biosynthetic cells may produce and store biologically inactive hormones in the form of pre- or prohormones. These can then be quickly converted into their active hormone form in response to a particular stimulus.

Effects of hormones

Hormones have the following effects on the body:
A hormone may also regulate the production and release of other hormones. Hormone signals control the internal environment of the body through homeostasis.

Chemical classes of hormones

Vertebrate hormones fall into three chemical classes:

Pharmacology

Many hormones and their analogues are used as medication. The most commonly prescribed hormones are estrogens and progestagens (as methods of hormonal contraception and as HRT), thyroxine (as levothyroxine, for hypothyroidism) and steroids (for autoimmune diseases and several respiratory disorders). Insulin is used by many diabetics. Local preparations for use in otolaryngology often contain pharmacologic equivalents of adrenaline, while steroid and vitamin D creams are used extensively in dermatological practice.
A "pharmacologic dose" of a hormone is a medical usage referring to an amount of a hormone far greater than naturally occurs in a healthy body. The effects of pharmacologic doses of hormones may be different from responses to naturally occurring amounts and may be therapeutically useful. An example is the ability of pharmacologic doses of glucocorticoid to suppress inflammation.

Important human hormones

See: List of human hormones

See also

References

  1. ^ Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetcke KP, Hoffmann JL, Morrow MS, Rodier DJ, Schaeffer JE, Touart LW, Zeeman MG, Patel YM (1998). "Environmental endocrine disruption: An effects assessment and analysis". Environ. Health Perspect. 106 (Suppl 1): 11–56. PMID 9539004. 
  2. ^ Beato M, Chavez S and Truss M (1996). "Transcriptional regulation by steroid hormones". Steroids 61 (4): 240–251. doi:10.1016/0039-128X(96)00030-X. PMID 8733009. 
  3. ^ Hammes SR (2003). "The further redefining of steroid-mediated signaling". Proc Natl Acad Sci USA 100 (5): 21680–2170. doi:10.1073/pnas.0530224100. PMID 12606724. 

External links

THYMUS

From Wikipedia, the free encyclopedia


Thymus
Illu thymus.jpg
Thymus
Gray1178.png
The thymus of a full-term fetus, exposed in situ.
Gray's subject #274 1273
Artery derived from internal mammary artery, superior thyroid artery, and inferior thyroid artery
Nerve vagus
Lymph tracheobronchial, parasternal
Precursor third branchial pouch
MeSH Thymus+gland
Dorlands/Elsevier Thymus
The thymus is a specialized organ in the immune system. The functions of the thymus are the "schooling" of T-lymphocytes (T cells), which are critical cells of the adaptive immune system, and the production and secretion of thymosins, hormones which control T-lymphocyte activities and various other aspects of the immune system. The thymus is composed of two identical lobes and is located anatomically in the anterior superior mediastinum, in front of the heart and behind the sternum.
Histologically, the thymus can be divided into a central medulla and a peripheral cortex which is surrounded by an outer capsule. The cortex and medulla play different roles in the development of T-cells. Cells in the thymus can be divided into thymic stromal cells and cells of hematopoietic origin (derived from bone marrow resident hematopoietic stem cells). Developing T-cells are referred to as thymocytes and are of hematopoietic origin. Stromal cells include thymic cortical epithelial cells, thymic medullary epithelial cells, and dendritic cells.
The thymus provides an inductive environment for development of T-lymphocytes from hematopoietic progenitor cells. In addition, thymic stromal cells allow for the selection of a functional and self-tolerant T-cell repertoire. Therefore, one of the most important roles of the thymus is the induction of central tolerance.
The thymus is largest and most active during the neonatal and pre-adolescent periods. By the early teens, the thymus begins to atrophy and thymic stroma is replaced by adipose (fat) tissue. Nevertheless, residual T lymphopoiesis continues throughout adult life.

 

History

The thymus was known to the Ancient Greeks, and its name comes from the Greek word θυμός (thumos), meaning heart, soul, desire, life — possibly because of its location in the chest, near where emotions are subjectively felt; or else the name comes from the herb thyme (also in Greek θυμός), which became the name for a "warty excrescence", possibly due to its resemblance to a bunch of thyme.[1][2]
Galen was the first to note that the size of the organ changed over the duration of a person's life.[3]
Due to the large numbers of apoptotic lymphocytes, the thymus was originally dismissed as a "lymphocyte graveyard", without functional importance. The importance of the thymus in the immune system was discovered in 1961 by Jacques Miller, by surgically removing the thymus from three day old mice, and observing the subsequent deficiency in a lymphocyte population, subsequently named T-cells after the organ of their origin.[4][5] Recently, advances in immunology have allowed the function of the thymus in T-cell maturation to be more fully understood.

Development

 Embryology

The two main components of the thymus, the lymphoid thymocytes and the thymic epithelial cells, have distinct developmental origins. The thymic epithelium is the first to develop, and appears in the form of two flask-shape endodermal diverticula, which arise, one on either side, from the third branchial pouch (pharyngeal pouch), and extend lateralward and backward into the surrounding mesoderm and neural crest-derived mesenchyme in front of the ventral aorta.
Here they meet and become joined to one another by connective tissue, but there is never any fusion of the thymus tissue proper. The pharyngeal opening of each diverticulum is soon obliterated, but the neck of the flask persists for some time as a cellular cord. By further proliferation of the cells lining the flask, buds of cells are formed, which become surrounded and isolated by the invading mesoderm. Additional portions of thymus tissue are sometimes developed from the fourth branchial pouches.[6]
During the late stages of the development of the thymic epithelium, hematopoietic bone-marrow precursors migrate into the thymus. Normal thymic development thereafter is dependant on the interaction between the thymic epithelium and the hematopoietic thymocytes.

Involution

The thymus continues to grow between birth and puberty and then begins to atrophy, a process directed by the high levels of circulating hormones. Proportional to thymic size, thymic activity (T-cell output) is most active before puberty. Upon atrophy, the size and activity are dramatically reduced, and the organ is primarily replaced with fat (a phenomenon known as "organ involution"). The atrophy is due to the increased circulating level of sex hormones, and chemical or physical castration of an adult results in the thymus increasing in size and activity.[7] Patients with the autoimmune disease Myasthenia gravis commonly (70%) are found to have thymic hyperplasia or malignancy.[8] The reason or order of these circumstances has yet to be determined by medical scientists.
Age Mass
birth about 15 grams;
puberty about 35 grams
twenty-five years 25 grams
sixty years less than 15 grams
seventy years as low as 5 grams

Anatomy

anterior view of chest showing location and size of adult thymus
The thymus is of a pinkish-gray color, soft, and lobulated on its surfaces. At birth it is about 5 cm in length, 4 cm in breadth, and about 6 mm in thickness.[9] The organ enlarges during childhood, and atrophies at puberty. Unlike the liver, kidney and heart, for instance, the thymus is at its largest in children. The thymus reaches maximum weight (20 to 37 grams) by the time of puberty. The thymus of older people is scarcely distinguishable from surrounding fatty tissue. As one ages the thymus slowly shrinks, eventually degenerating into tiny islands of fatty tissue. By the age of 75 years, the thymus weighs only 6 grams. In children the thymus is grayish-pink in colour and in adults it is yellow.
The thymus will, if examined when its growth is most active, be found to consist of two lateral lobes placed in close contact along the middle line, situated partly in the thorax, partly in the neck, and extending from the fourth costal cartilage upward, as high as the lower border of the thyroid gland. It is covered by the sternum, and by the origins of the sternohyoidei and sternothyreoidei.[9] Below, it rests upon the pericardium, being separated from the aortic arch and great vessels by a layer of fascia. In the neck, it lies on the front and sides of the trachea, behind the sternohyoidei and sternothyreoidei. The two lobes differ slightly in size and may be united or separated.[9]

Structure

Histology
Minute structure of thymus.
Micrograph showing a thymic corpuscle (Hassall corpuscle), a characteristic histologic feature of the human thymus. H&E stain.
Each lateral lobe is composed of numerous lobules held together by delicate areolar tissue; the entire organ being enclosed in an investing capsule[10] of a similar but denser structure. The primary lobules vary in size from that of a pin's head to that of a small pea, and are made up of a number of small nodules or follicles.
The follicles are irregular in shape and are more or less fused together, especially toward the interior of the organ. Each follicle is from 1 to 2 mm in diameter and consists of a medullary and a cortical portion[11], and these differ in many essential particulars from each other.

Cortex

The cortical portion is mainly composed of lymphoid cells, supported by a network of finely-branched epithelial reticular cells, which is continuous with a similar network in the medullary portion. This network forms an adventitia to the blood vessels.
The cortex is the location of the earliest events in thymocyte development, where T cell receptor gene rearrangement and positive selection takes place.

Medulla

In the medullary portion, the reticulum is coarser than in the cortex, the lymphoid cells are relatively fewer in number, and there are found peculiar nest-like bodies, the concentric corpuscles of Hassall. These concentric corpuscles are composed of a central mass, consisting of one or more granular cells, and of a capsule formed of epithelioid cells. They are the remains of the epithelial tubes, which grow out from the third branchial pouches of the embryo to form the thymus. Each follicle is surrounded by a vascular plexus, from which vessels pass into the interior, and radiate from the periphery toward the center, forming a second zone just within the margin of the medullary portion. In the center of the medullary portion there are very few vessels, and they are of minute size.
The medulla is the location of the latter events in thymocyte development. Thymocytes that reach the medulla have already successfully undergone T cell receptor gene rearrangement and positive selection, and have been exposed to a limited degree of negative selection. The medulla is specialised to allow thymocytes to undergo additional rounds of negative selection to remove auto-reactive T-cells from the mature repertoire. The gene AIRE is expressed by the thymic medullary epithelium, and drives the transcription of organ-specific genes such as insulin to allow maturing thymocytes to be exposed to a more complex set of self-antigens than is present in the cortex.

Vasculature

The arteries supplying the thymus are derived from the internal mammary, and from the superior thyroid and inferior thyroids.
The veins end in the left brachiocephalic vein (innominate vein) , and in the thyroid veins.
The nerves are exceedingly minute; they are derived from the vagi and sympathetic nervous system. Branches from the descendens hypoglossi and phrenic reach the investing capsule, but do not penetrate into the substance of the organ.

Function

In the two thymic lobes, hematopoietic precursors from the bone-marrow, referred to as thymocytes, mature into T-cells. Once mature, T-cells emigrate from the thymus and constitute the peripheral T-cell repertoire responsible for directing many facets of the adaptive immune system. Loss of the thymus at an early age through genetic mutation (as in DiGeorge Syndrome[12]) results in severe immunodeficiency and a high susceptibility to infection.[13]
The stock of T-lymphocytes is built up in early life, so the function of the thymus is diminished in adults. It is largely degenerated in elderly adults and is barely identifiable, consisting mostly of fatty tissue, but it continues its endocrine function.[14] Involution of the thymus has been linked to loss of immune function in the elderly, susceptibility to infection and to cancer.
The ability of T-cells to recognize foreign antigens is mediated by the T cell receptor. The T cell receptor undergoes genetic rearrangement during thymocyte maturation, resulting in each T-cell bearing a unique T-cell receptor, specific to a limited set of peptide:MHC combinations. The random nature of the genetic rearrangement results in a requirement of central tolerance mechanisms to remove or inactivate those T cells which bear a T cell receptor with the ability to recognise self-peptides.

Phases of thymocyte maturation

The generation of T-cells expressing distinct T-cell receptors occurs within the thymus, and can be conceptually divided into three phases:
  1. A rare population of hematopoietic progenitor cells enter the thymus from the blood, and expands by cell division to generate a large population of immature thymocytes.[15]
  2. Immature thymocytes each make distinct T-cell receptors by a process of gene rearrangement. This process is error-prone, and some thymocytes fail to make functional T-cell receptors, whereas other thymocytes make T-cell receptors that are autoreactive.[16]
  3. Immature thymocytes undergo a process of selection, based on the specificity of their T-cell receptors. This involves selection of T-cells that are functional (positive selection), and elimination of T-cells that are autoreactive (negative selection).
type: functional (positive selection) autoreactive (negative selection)
location: cortex medulla
Intrathymic T Cell Differentiation.JPG In order to be positively-selected, thymocytes will have to interact with several cell surface molecules, MHC/HLA, to ensure reactivity and specificity[17].
Positive selection eliminates (apoptosis) weak binding cells and only takes high medium binding cells. (Binding refers to the ability of the T-cell receptors to bind to either MHC class I/II or peptide molecules.)
Negative selection is not 100% complete. Some autoreactive T-cells escape thymic censorship, and are released into the circulation.
Additional mechanisms of tolerance active in the periphery exist to silence these cells such as anergy, deletion, and regulatory T cells.
If these peripheral tolerance mechanisms also fail, autoimmunity may arise.
Cells that pass both levels of selection are released into the bloodstream to perform vital immune functions.

Disease Associations

Immunodeficiency

As the thymus is the organ of T-cell development, any congenital defect in thymic genesis or a defect in thymocyte development can lead to a profound T cell primary immunodeficiency. Defects that affect both the T cell and B cell lymphocyte lineages result in Severe Combined Immunodeficiency Syndrome (SCID). Acquired T cell deficiencies can also affect thymocyte development in the thymus.

 DiGeorge Syndrome

DiGeorge Syndrome is a genetic disorder caused by the deletion of a small section of chromosome 22. This results in a midline congenital defect including thymic aplasia, or congenital deficiency of a thymus. Patients may present with a profound immunodeficiency disease, due to the lack of T cells. No other immune cell lineages are affected by the congenital absence of the thymus. DiGeorge Syndrome is the most common congenital cause of thymic aplasia in humans. In mice, the nude mouse strain are congenitally thymic deficent. These mice are an important model of primary T cell deficiency.

SCID

Severe combined immunodeficiency syndromes (SCID) are group of rare congenital genetic diseases that result in combined T lymphocyte and B lymphocyte deficencies. These syndromes are cause by defective hematopoietic progenitor cells which are the precursors of both B- and T-cells. This results in a severe reduction in developing thymocytes in the thymus and consequently thymic atrophy. A number of genetic defects can cause SCID, including IL-7 receptor deficiency, common gamma chain deficiency, and Recombination activating gene deficiency.

HIV / AIDS

The HIV virus causes an acquired T-cell immunodeficiency syndrome (AIDS) by specifically killing CD4+ T-cells. Whereas the major effect of the virus is on mature peripheral T-cells, the HIV virus can also infect developing thymocytes in the thymus, most of which express CD4.

Autoimmune Disease

Autoimmune diseases are caused by a hyperactive immune system that instead of attacking foreign pathogens reacts against the host organism (self) causing disease. One of the primary functions of the thymus is to prevent autoimmunity through the process of central tolerance, immunologic tolerance to self antigens.

APECED

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) is an extremely rare genetic autoimmune syndrome. However, this disease highlights the importance of the thymus in prevention of autoimmunity. This disease is caused by deficiency of the Autoimmune Regulator (AIRE) gene in the thymus. AIRE allows for the ectopic expression of tissue-specific proteins in the thymus medulla, such as proteins that would normally only be expressed in the eye or pancreas. This expression in the thymus, allows for the deletion of autoreactive thymocytes by exposing them to self-antigens during their development, a mechansism of central tolerance. Patients with APECED develop an autoimmune disease that affects multiple endocrine tissues.

Myasthenia gravis

Myasthenia gravis is an autoimmune disease caused by antibodies that block acetylcholine receptors. Myasthenia gravis is often associated with thymic hypertrophy. Thymectomy may be necessary to treat the disease.

Cancer

Two primary forms of tumours originate in the thymus.

Thymomas

Tumours originating from the thymic epithelial cells are called thymomas, and are found in about 10-15% of patients with myasthenia gravis.[18] Symptoms are sometimes confused with bronchitis or a strong cough because the tumour presses on the recurrent laryngeal nerve. All thymomas are potentially cancerous, but they can vary a great deal. Some grow very slowly. Others grow rapidly and can spread to surrounding tissues. Treatment of thymomas often requires surgery to remove the entire thymus.

Lymphomas

Tumours originating from the thymocytes are called thymic lymphomas.[18] Lymphomas or leukemias of thymocyte origin are classified as Precursor T acute lymphoblastic leukemia/lymphoma (T-ALL).
People with an enlarged thymus, particularly children, were treated with intense radiation in the years before 1950. There is an elevated incidence of thyroid cancer and leukemia in treated individuals.[19]

Thymectomy

Thymectomy is the surgical removal of the thymus. The most common reason for thymectomy in the United States is to gain surgical access to the heart in surgeries to correct congenital heart defects that are performed in the neonatal period. In neonates, but not older children or adults, the relative size of the thymus obstructs surgical access to the heart. Surprisingly, removal of the thymus does not result in a T cell immunodeficiency. This is because sufficient T cells are generated during fetal life prior to birth. These T cells are long-lived and can proliferate by homeostatic proliferation throughout the lifetime of the patient. However, there is evidence of premature immune aging in patients thymectomized during early childhood [20].
Other indications for thymectomy include the removal of thymomas and the treatment of myastenia gravis. Thymectomy is not indicated for the treatment of primary thymic lymphomas. However, a thymic biopsy may be necessary to make the pathologic diagnosis.

Second thymus

The thymus is also present in most vertebrates, with similar structure and function as the human thymus. Some animals have multiple secondary (smaller) thymi in the neck; this phenomenon has been reported for mice [21] and also occurs in 5 out of 6 human fetuses.[22] As in humans, the Guinea pig's thymus naturally atrophies as the animal reaches adulthood, but in the athymic hairless guinea pig (which arose from a spontaneous laboratory mutation) possessed no thymic tissue whatsoever, and the organ cavity is replaced with cystic spaces.
Animal thymic tissue sold in a butcher shop or at a meat counter is known as sweetbread.

In animals

A sheep thymus, several times enlarged, in Peste des petits ruminants
Thymus is present in mammals, where it plays the same immunological function as in human beings.

References

  1. ^ Online Etymology Dictionary
  2. ^ Liddell Scott Greek-English Lexicon
  3. ^ Nishino M, Ashiku SK, Kocher ON, Thurer RL, Boiselle PM, Hatabu H (2006). "The thymus: a comprehensive review". Radiographics 26 (2): 335–48. doi:10.1148/rg.262045213. PMID 16549602. http://radiographics.rsnajnls.org/cgi/content/full/26/2/335. 
  4. ^ Miller JF (2002). "The discovery of thymus function and of thymus-derived lymphocytes". Immunol. Rev. 185: 7–14. doi:10.1034/j.1600-065X.2002.18502.x. PMID 12190917. 
  5. ^ Miller JF (2004). "Events that led to the discovery of T-cell development and function--a personal recollection". Tissue Antigens 63 (6): 509–17. doi:10.1111/j.0001-2815.2004.00255.x. PMID 15140026. 
  6. ^ Swiss embryology (from UL, UB, and UF) qblood/lymphat03
  7. ^ Sutherland JS. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005 15;175(4):2741-53
  8. ^ Kumar, Parveen, Michael Clark (2002). Clinical Medicine 5th edn.. Saunders. pp. 1222. ISBN 0-702-02606-9. 
  9. ^ a b c Gray, H. (1918). (bartleby.com) "4c. The Thymus". Anatomy of the Human Body. Philadelphia: Lea & Febiger. http://www.bartleby.com/107/274.html (bartleby.com). 
  10. ^ Histology at BU 07403loa
  11. ^ Histology at BU 07401loa
  12. ^ Hussain, I., P.H. Win and S. Guduri (February 2, 2006). "DiGeorge Syndrome". eMedicine. http://www.emedicine.com/med/topic567.htm. Retrieved 2008-09-29. 
  13. ^ Miller JF. The discovery of thymus function and of thymus-derived lymphocytes. Immunol Rev 185:7-14, 2002. full text
  14. ^ "Thymus". http://www.tiscali.co.uk/reference/encyclopaedia/hutchinson/m0008212.html. Retrieved 2007-12-03. 
  15. ^ Schwarz BA, Bhandoola A. Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis. Immunol Rev 209:47, 2006. full text
  16. ^ Sleckman BP, Lymphocyte antigen receptor gene assembly: multiple layers of regulation. Immunol Res 32:153-8, 2005. full text
  17. ^ Baldwin TA, Hogquist KA, Jameson SC, The fourth way? Harnessing aggressive tendencies in the thymus. “J Immunol.” 173:6515-20, 2004. [1]
  18. ^ a b Huete-Garin, A.; S.S. Sagel (2005). "Chapter 6: "Mediastinum", Thymic Neoplasm". In J.K.T. Lee, S.S. Sagel, R.J. Stanley and J.P. Heiken. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott Williams & Wilkins. pp. 311–324. ISBN 0781745268. 
  19. ^ Shore RE, Woodward E, Hildreth N, et al., Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74:1177-1184, 1985.
  20. ^ [2]
  21. ^ Terszowski G et al. (2006) Evidence for a Functional Second Thymus in Mice. Science. 2 March 2006. PMID 16513945
  22. ^ Surprise organ discovered in mice, Nature News, 2 March 2006
  • This article was originally based on an entry from a public domain edition of Gray's Anatomy. As such, some of the information contained within it may be outdated.

 Additional images